Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...
BOSTON, October 21, 2024 – Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a …
OFF
Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...
1 week from now
BOSTON, October 21, 2024 – Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a …
generalatlantic.com
OFF
Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...
1 week from now
Oct 21, 2024 · Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round. Financing led by General Atlantic with participation from T. Rowe Price Associates, …
businesswire.com
OFF
PureTech Founded Entity Seaport Therapeutics Closes $225 Million ...
1 week from now
BOSTON, October 21, 2024--PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
yahoo.com
OFF
Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...
1 week from now
BOSTON, October 21, 2024--Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven …
yahoo.com
OFF
Seaport Therapeutics Closes $225 Million Oversubscribed
1 week from now
Oct 21, 2024 · BOSTON-- (BUSINESS WIRE)--Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel …
biospace.com
OFF
PureTech Founded Entity Seaport Therapeutics Closes $225 Million ...
1 week from now
Oct 21, 2024 · Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round. ... today announced the closing of an oversubscribed $225 million Series B financing …
streetinsider.com
OFF
Seaport Therapeutics Closes $225 Million Financing Round
1 week from now
Oct 24, 2024 · Neuropsychiatric medicines company Seaport Therapeutics has closed an oversubscribed $225 million Series B financing round. The financing brings the total capital …
ispeboston.org
OFF
Seaport Therapeutics Secures US$225 Series B Funding To Develop ...
1 week from now
Oct 23, 2024 · The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform originally developed by Monash University, has announced the …
monash.edu
OFF
PureTech Founded Entity Seaport Therapeutics Closes $225 Million ...
1 week from now
Oct 21, 2024 · PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport …
marketscreener.com
OFF
Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...
1 week from now
Oct 21, 2024 · Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven …
tmcnet.com
OFF
Seaport Eyes Platform, Pipeline Growth With $225M Series B
1 week from now
Oct 21, 2024 · Daphne Zohar, founder and CEO of Seaport Therapeutics. Seaport Therapeutics said today it has closed on an oversubscribed $225 million Series B financing, with the …
genengnews.com
OFF
Seaport Therapeutics Closes $225 Million Series B Financing …
1 week from now
Oct 21, 2024 · Seaport Therapeutics successfully closes a $225 million Series B financing round, marking a total capital of $325 million since its launch in April 2024. PureTech retains 36.7% …
venturecapital.com
OFF
Seaport Therapeutics Closes $225 Million Financing
1 week from now
Oct 21, 2024 · Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in …
thepharmaletter.com
OFF
Seaport Therapeutics Raises $225 Million In Series B Financing
1 week from now
Oct 29, 2024 · The WilmerHale team representing Seaport consisted of Stuart Falber, Riley O’Brien and Emily Ivers. On October 21, 2024, Seaport Therapeutics, a clinical-stage …
wilmerhale.com
OFF
Seaport Therapeutics Closes $225 Million Series B To Develop ...
1 week from now
Oct 22, 2024 · Boston biotech secures funds to advance depression, anxiety drug. Seaport Therapeutics closes $225 million Series B to develop neuropsychiatric drugs. The Boston …
outsourcing-pharma.com
OFF
PureTech Founded Entity Seaport Therapeutics Closes $225 Million ...
1 week from now
Oct 21, 2024 · Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round. Financing led by General Atlantic with participation from T. Rowe Price Associates, …
financialcontent.com
OFF
Aclaris Therapeutics Announces $80 Million Private Placement
1 week from now
7 hours ago · WAYNE, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS) (the “Company” or “Aclaris”), a clinical-stage biopharmaceutical company …
yahoo.com
OFF
PRTC's Seaport Closes $225M Series B Financing
1 week from now
21 October 2024. 21 October 2024. PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round. Financing led by General Atlantic with …
sharesmagazine.co.uk
FAQs about Seaport Therapeutics Closes $225 Million Oversubscribed Series B ... Coupon?
What happened to seaport Therapeutics?
Who is seaport Therapeutics?
How much money did seaport raise in 2024?
Does PureTech own seaport?
What is seaport's glyph platform?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
